Quality of 2019 American optometric association clinical practice guideline for diabetic eye care

This plain language summary for patients serves as an overview in explaining hoarseness (dysphonia). The summary applies to patients in all age groups and is based on the 2018 “Clinical Practice Guideline: Hoarseness (Dysphonia) (Update).” The evidence-based guideline includes research to support more effective identification and management of patients with hoarseness (dysphonia). The primary purpose of the guideline is to improve the quality of care for patients with hoarseness (dysphonia) based on current best evidence.

Download Full-text

The AGREE Reporting Checklist is useful for assessing the quality of clinical practice guideline development

BMJ ◽

10.1136/bmj.i2027 ◽

2016 ◽

pp. i2027 ◽

Cited By ~ 2

Author(s):

Greg Irving

Keyword(s):

Clinical Practice ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Guideline Development ◽

Clinical Practice Guideline Development

Download Full-text

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer

Journal for ImmunoTherapy of Cancer ◽

10.1136/jitc-2021-002552 ◽

2021 ◽

Vol 9 (7) ◽

pp. e002552

Author(s):

Matthew D Galsky ◽

Arjun V Balar ◽

Peter C Black ◽

Matthew T Campbell ◽

Gail S Dykstra ◽

...

Keyword(s):

Clinical Practice ◽

Patient Outcomes ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Urothelial Cancer ◽

Diagnostic Testing ◽

Care Providers ◽

Immunotherapy Of Cancer ◽

Selection Of

A number of immunotherapies have been developed and adopted for the treatment of urothelial cancer (encompassing cancers arising from the bladder, urethra, or renal pelvis). For these immunotherapies to positively impact patient outcomes, optimal selection of agents and treatment scheduling, especially in conjunction with existing treatment paradigms, is paramount. Immunotherapies also warrant specific and unique considerations regarding patient management, emphasizing both the prompt identification and treatment of potential toxicities. In order to address these issues, the Society for Immunotherapy of Cancer (SITC) convened a panel of experts in the field of immunotherapy for urothelial cancer. The expert panel developed this clinical practice guideline (CPG) to inform healthcare professionals on important aspects of immunotherapeutic treatment for urothelial cancer, including diagnostic testing, treatment planning, immune-related adverse events (irAEs), and patient quality of life (QOL) considerations. The evidence- and consensus-based recommendations in this CPG are intended to give guidance to cancer care providers treating patients with urothelial cancer.

Download Full-text

Appraising the methodological quality of the clinical practice guideline for diabetes mellitus using the AGREE II instrument: a methodological evaluation

JRSM Open ◽

10.1177/2054270416682673 ◽

2017 ◽

Vol 8 (2) ◽

pp. 205427041668267 ◽

Cited By ~ 13

Author(s):

Mahmoud Radwan ◽

Ali Akbari Sari ◽

Arash Rashidian ◽

Amirhossein Takian ◽

Sanaa Abou-Dagga ◽

...

Keyword(s):

Diabetes Mellitus ◽

Clinical Practice ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Methodological Quality ◽

Arabic Version ◽

Agree Ii ◽

Agree Ii Instrument ◽

Methodological Evaluation

Objectives To evaluate the methodological quality of the Palestinian Clinical Practice Guideline for Diabetes Mellitus using the Translated Arabic Version of the AGREE II. Design Methodological evaluation. A cross-cultural adaptation framework was followed to translate and develop a standardised Translated Arabic Version of the AGREE II. Setting Palestinian Primary Healthcare Centres. Participants Sixteen appraisers independently evaluated the Clinical Practice Guideline for Diabetes Mellitus using the Translated Arabic Version of the AGREE II. Main outcome measures Methodological quality of diabetic guideline. Results The Translated Arabic Version of the AGREE II showed an acceptable reliability and validity. Internal consistency ranged between 0.67 and 0.88 (Cronbach’s α). Intra-class coefficient among appraisers ranged between 0.56 and 0.88. The quality of this guideline is low. Both domains ‘Scope and Purpose’ and ‘Clarity of Presentation’ had the highest quality scores (66.7% and 61.5%, respectively), whereas the scores for ‘Applicability’, ‘Stakeholder Involvement’, ‘Rigour of Development’ and ‘Editorial Independence’ were the lowest (27%, 35%, 36.5%, and 40%, respectively). Conclusions The findings suggest that the quality of this Clinical Practice Guideline is disappointingly low. To improve the quality of current and future guidelines, the AGREE II instrument is extremely recommended to be incorporated as a gold standard for developing, evaluating or updating the Palestinian Clinical Practice Guidelines. Future guidelines can be improved by setting specific strategies to overcome implementation barriers with respect to economic considerations, engaging of all relevant end-users and patients, ensuring a rigorous methodology for searching, selecting and synthesising the evidences and recommendations, and addressing potential conflict of interests within the development group.

Download Full-text

Clinical Practice Guideline: Ménière’s Disease Executive Summary

Otolaryngology ◽

10.1177/0194599820909439 ◽

2020 ◽

Vol 162 (4) ◽

pp. 415-434 ◽

Cited By ~ 5

Author(s):

Gregory J. Basura ◽

Meredith E. Adams ◽

Ashkan Monfared ◽

Seth R. Schwartz ◽

Patrick J. Antonelli ◽

...

Keyword(s):

Hearing Loss ◽

Clinical Practice ◽

Sensorineural Hearing Loss ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Meniere’S Disease ◽

Sensorineural Hearing ◽

Ménière’S Disease ◽

Ménière's Disease

Objective Ménière’s disease (MD) is a clinical condition defined by spontaneous vertigo attacks (each lasting 20 minutes to 12 hours) with documented low- to midfrequency sensorineural hearing loss in the affected ear before, during, or after one of the episodes of vertigo. It also presents with fluctuating aural symptoms (hearing loss, tinnitus, or ear fullness) in the affected ear. The underlying etiology of MD is not completely clear, yet it has been associated with inner ear fluid volume increases, culminating in episodic ear symptoms (vertigo, fluctuating hearing loss, tinnitus, and aural fullness). Physical examination findings are often unremarkable, and audiometric testing may or may not show low- to midfrequency sensorineural hearing loss. Imaging, if performed, is also typically normal. The goals of MD treatment are to prevent or reduce vertigo severity and frequency; relieve or prevent hearing loss, tinnitus, and aural fullness; and improve quality of life. Treatment approaches to MD are many, and approaches typically include modifications of lifestyle factors (eg, diet) and medical, surgical, or a combination of therapies. Purpose The primary purpose of this clinical practice guideline is to improve the quality of the diagnostic workup and treatment outcomes of MD. To achieve this purpose, the goals of this guideline are to use the best available published scientific and/or clinical evidence to enhance diagnostic accuracy and appropriate therapeutic interventions (medical and surgical) while reducing unindicated diagnostic testing and/or imaging.

Download Full-text

Physical Therapist Clinical Practice Guideline for the Management of Individuals With Heart Failure

Physical Therapy ◽

10.1093/ptj/pzz127 ◽

2020 ◽

Vol 100 (1) ◽

pp. 14-43

Author(s):

Michael J Shoemaker ◽

Konrad J Dias ◽

Kristin M Lefebvre ◽

John D Heick ◽

Sean M Collins

Keyword(s):

Heart Failure ◽

Decision Making ◽

Clinical Practice ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Clinical Decision Making ◽

Physical Therapists ◽

Physical Therapist ◽

Clinical Decision

Abstract The American Physical Therapy Association (APTA), in conjunction with the Cardiovascular and Pulmonary Section of APTA, have commissioned the development of this clinical practice guideline to assist physical therapists in their clinical decision making when managing patients with heart failure. Physical therapists treat patients with varying degrees of impairments and limitations in activity and participation associated with heart failure pathology across the continuum of care. This document will guide physical therapist practice in the examination and treatment of patients with a known diagnosis of heart failure. The development of this clinical practice guideline followed a structured process and resulted in 9 key action statements to guide physical therapist practice. The level and quality of available evidence were graded based on specific criteria to determine the strength of each action statement. Clinical algorithms were developed to guide the physical therapist in appropriate clinical decision making. Physical therapists are encouraged to work collaboratively with other members of the health care team in implementing these action statements to improve the activity, participation, and quality of life in individuals with heart failure and reduce the incidence of heart failure-related re-admissions.

Download Full-text

Clinical Practice Guideline: Ménière’s Disease

Otolaryngology ◽

10.1177/0194599820909438 ◽

2020 ◽

Vol 162 (2_suppl) ◽

pp. S1-S55 ◽

Cited By ~ 5

Author(s):

Gregory J. Basura ◽

Meredith E. Adams ◽

Ashkan Monfared ◽

Seth R. Schwartz ◽

Patrick J. Antonelli ◽

...

Keyword(s):

Hearing Loss ◽

Clinical Practice ◽

Sensorineural Hearing Loss ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Meniere’S Disease ◽

Sensorineural Hearing ◽

Ménière’S Disease ◽

Ménière's Disease

Objective Ménière’s disease (MD) is a clinical condition defined by spontaneous vertigo attacks (each lasting 20 minutes to 12 hours) with documented low- to midfrequency sensorineural hearing loss in the affected ear before, during, or after one of the episodes of vertigo. It also presents with fluctuating aural symptoms (hearing loss, tinnitus, or ear fullness) in the affected ear. The underlying etiology of MD is not completely clear, yet it has been associated with inner ear fluid (endolymph) volume increases, culminating in episodic ear symptoms (vertigo, fluctuating hearing loss, tinnitus, and aural fullness). Physical examination findings are often unremarkable, and audiometric testing may or may not show low- to midfrequency sensorineural hearing loss. Conventional imaging, if performed, is also typically normal. The goals of MD treatment are to prevent or reduce vertigo severity and frequency; relieve or prevent hearing loss, tinnitus, and aural fullness; and improve quality of life. Treatment approaches to MD are many and typically include modifications of lifestyle factors (eg, diet) and medical, surgical, or a combination of therapies. Purpose The primary purpose of this clinical practice guideline is to improve the quality of the diagnostic workup and treatment outcomes of MD. To achieve this purpose, the goals of this guideline are to use the best available published scientific and/or clinical evidence to enhance diagnostic accuracy and appropriate therapeutic interventions (medical and surgical) while reducing unindicated diagnostic testing and/or imaging.

Download Full-text

Adherence to the RIGHT statement in Society of Interventional Radiology guidelines

Journal of Osteopathic Medicine ◽

10.1515/jom-2020-0024 ◽

2021 ◽

Vol 121 (1) ◽

pp. 11-24

Author(s):

Mostafa Khattab ◽

Benjamin Howard ◽

Shafiq Al-Rifai ◽

Trevor Torgerson ◽

Matt Vassar

Keyword(s):

Interventional Radiology ◽

Clinical Practice ◽

Clinical Practice Guidelines ◽

Practice Guidelines ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Venous Disease ◽

Quality Of Reporting ◽

The Right

Abstract Context The Reporting Items for Practice Guidelines in Health Care (RIGHT) Statement was developed by a multidisciplinary team of experts to improve reporting quality and transparency in clinical practice guideline development. Objective To assess the quality of reporting in clinical practice guidelines put forth by the Society of Interventional Radiology (SIR) and their adherence to the RIGHT statement checklist. Methods In March 2018, using the 22 criteria listed in the RIGHT statement, two researchers independently documented adherence to each item for all eligible guidelines listed by the SIR by reading through each guideline and using the RIGHT statement elaboration and explanation document as a guide to determine if each item was appropriately addressed as listed in the checklist. To qualify for inclusion in this study, each guideline must have met the strict definition for a clinical practice guideline as set forth by the National Institute of Health and the Institute of Medicine, meaning they were informed by a systematic review of evidence and intended to direct patient care and physician decisions. Guidelines were excluded if they were identified as consensus statements, position statements, reporting standards, and training standards or guidelines. After exclusion criteria were applied, the two researchers scored each of the remaining clinical practice guidelines (CPGs) using a prespecified abstraction Google form that reflected the RIGHT statement checklist (22 criteria; 35 items inclusive of subset questions). Each item on the abstraction form consisted of a “yes/no” option; each item on the RIGHT checklist was recorded as “yes” if it was included in the guideline and “no” if it was not. Each checklist item was weighed equally. Partial adherence to checklist items was recorded as “no.” Data were extracted into Microsoft Excel (Microsoft Corporation) for statistical analysis. Results The initial search results yielded 129 CPGs in the following areas: 13 of the guidelines were in the field of interventional oncology; 16 in neurovascular disorders; five in nonvascular interventions; four in pediatrics; 25 in peripheral, arterial, and aortic disease; one in cardiac; one in portal and mesenteric vascular disease; 37 in practice development and safety; three in spine and musculoskeletal disorders; 14 in venous disease; five in renal failure/hemodialysis; and five in women’s health. Of the 46 guidelines deemed eligible for evaluation by the RIGHT checklist, 12 of the checklist items showed less than 25% adherence and 13 showed more than 75% adherence. Of 35 individual RIGHT statement checklist items, adherence was found for a mean (SD) of 22.9 items (16.3). The median number of items with adherence was 21 (interquartile range, 7.5–38). Conclusion The quality of reporting in interventional radiology guidelines is lacking in several key areas, including whether patient preferences were considered, whether costs and resources were considered, the strength of the recommendations, and the certainty of the body of evidence. Poor adherence to the RIGHT statement checklist in these guidelines reveals many areas for improvement in guideline reporting.

Download Full-text